Document is current
Any future updates will be listed below
-
Authors
Willsey, Matthew S. https://orcid.org/0000-0003-2093-7733
Shah, Nishal P.
Avansino, Donald T.
Hahn, Nick V. https://orcid.org/0009-0004-1663-2018
Jamiolkowski, Ryan M. https://orcid.org/0000-0002-3119-7788
Kamdar, Foram B. https://orcid.org/0009-0000-2734-3247
Hochberg, Leigh R. https://orcid.org/0000-0003-0261-2273
Willett, Francis R.
Henderson, Jaimie M. https://orcid.org/0000-0002-3276-2267
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 3 October 2024
First Online: 20 January 2025
Competing interests
: L.R.H.: the Massachusetts General Hospital Translational Research Center has clinical research support agreements with Axoft, Neuralink, Neurobionics, Precision Neuro, Synchron and Reach Neuro, for which L.R.H. provides consultative input. L.R.H. is a co-investigator on a US National Institutes of Health Small Business Innovation Research grant with Paradromics, and is a non-compensated member of the board of directors of a nonprofit assistive communication device technology foundation (Speak Your Mind Foundation). Mass General Brigham is convening the Implantable Brain–Computer Interface Collaborative Community (iBCI-CC); charitable gift agreements to Mass General Brigham, including those received so far from Paradromics, Synchron, Precision Neuro, Neuralink and Blackrock Neurotech, support the iBCI-CC, for which L.R.H. provides effort. J.M.H. is a consultant for Neuralink, Enspire DBS and Paradromics; holds equity (stock options) in MapLight Therapeutics; and is co-founder and shareholder in Re-EmergeDBS. J.M.H. and F.R.W. are inventors of intellectual property licensed by Stanford University to Blackrock Neurotech and Neuralink (‘Systems and methods for decoding intended symbols from neural activity’. K.V. Shenoy, J.M. Henderson, F.R. Willett - US Patent 12,026,311, 2024). The other authors declare no competing interests.
